Psychopharmacology and Psychiatry Updates

264 Episoade

1. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

   Publicat: 23.11.2021
2. Subclinical Hypothyroidism in Depressed Adolescents

   Publicat: 18.11.2021
3. Principles for Managing Alcohol Use Disorder

   Publicat: 13.11.2021
4. ECT for Depressed Patients With Borderline Personality Disorder

   Publicat: 08.11.2021
5. Assessing and Treating Alcohol Withdrawal

   Publicat: 03.11.2021
6. Lab Tests in Psychopharmacology

   Publicat: 29.10.2021
7. Technology-Facilitated Adherence Enhancement and Family Involvement

   Publicat: 24.10.2021
8. Drug-Induced Hyperthermic Syndromes in Psychiatry

   Publicat: 19.10.2021
9. How to Improve Adherence: Targeting Reasons for Nonadherence

   Publicat: 14.10.2021
10. Esketamine: Postmarketing Safety Concerns

    Publicat: 09.10.2021
11. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Publicat: 04.10.2021
12. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Publicat: 29.09.2021
13. How to Assess Psychotropic Drug Adherence

    Publicat: 24.09.2021
14. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Publicat: 19.09.2021
15. Delirium, Catatonia, and COVID-19

    Publicat: 14.09.2021
16. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Publicat: 09.09.2021
17. Dopamine and Depression: Clinical Considerations

    Publicat: 04.09.2021
18. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Publicat: 30.08.2021
19. New Somatic Treatments for Child and Adolescent Depression

    Publicat: 25.08.2021
20. Management of Delirium: Nonpharmacologic Strategies

    Publicat: 20.08.2021